Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone Ointment
NDC Package 24208-785-55
Package Information
Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone (neomycin sulfate and polymyxin b sulfate, bacitracin zinc and hydrocortisone) ointment is neomycin and polymyxin B sulfates, bacitracin zinc and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists.Ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. This formulation utilizes a ointment delivery system. Marketed by Bausch & Lomb Incorporated, this product is identified by NDC 24208-785 and is authorized under FDA application ANDA064068.
Identification & Billing
- RxCUI: 1116150 - bacitracin zinc 400 UNT / hydrocortisone acetate 10 MG / neomycin sulfate 3.5 MG / polymyxin B sulfate 10,000 UNT per GM Ophthalmic Ointment
- RxCUI: 1116150 - bacitracin zinc 0.4 UNT/MG / hydrocortisone acetate 0.01 MG/MG / neomycin sulfate 0.0035 MG/MG / polymyxin B sulfate 10 UNT/MG Ophthalmic Ointment
- RxCUI: 1116150 - bacitracin zinc 400 UNT/GM / hydrocortisone acetate 1 % / neomycin sulfate 3.5 MG/GM / polymyxin B sulfate 10,000 UNT/GM Ophthalmic Ointment
Clinical Specifications
- Aminoglycoside Antibacterial - [EPC] (Established Pharmacologic Class)
- Aminoglycosides - [CS]
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Decreased Cell Wall Synthesis & Repair - [PE] (Physiologic Effect)
- Polymyxin-class Antibacterial - [EPC] (Established Pharmacologic Class)
- Polymyxins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 24208 - Bausch & Lomb Incorporated
- 24208-785 - Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone
- 24208-785-55 - 1 TUBE in 1 CARTON / 3.5 g in 1 TUBE
- 24208-785 - Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 24208-785-55 identifies a specific commercial package of 1 tube in 1 carton / 3.5 g in 1 tube of Neomycin And Polymyxin B Sulfates, Bacitracin Zinc And Hydrocortisone, a human prescription drug labeled by Bausch & Lomb Incorporated. This ointment is formulated for ophthalmic use and contains bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch & Lomb Incorporated on October 30, 1995. The current certification is valid through December 31, 2026.
How is this Bausch & Lomb Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 24208078555. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 3.5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.